2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

  1. Landmesser, U.
  2. Chapman, M.J.
  3. Stock, J.K.
  4. Amarenco, P.
  5. Belch, J.J.F.
  6. Borén, J.
  7. Farnier, M.
  8. Ference, B.A.
  9. Gielen, S.
  10. Graham, I.
  11. Grobbee, D.E.
  12. Hovingh, G.K.
  13. Lüscher, T.F.
  14. Piepoli, M.F.
  15. Ray, K.K.
  16. Stroes, E.S.
  17. Wiklund, O.
  18. Windecker, S.
  19. Zamorano, J.L.
  20. Pinto, F.
  21. Tokgözoǧlu, L.
  22. Bax, J.J.
  23. Catapano, A.L.
Aldizkaria:
European Heart Journal

ISSN: 1522-9645,  0195-668X

Argitalpen urtea: 2018

Alea: 39

Zenbakia: 14

Orrialdeak: 1131-1143

Mota: Berrikuspena

DOI: 10.1093/EURHEARTJ/EHX549 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus